Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...

In a massive supply chain cyberattack, Oracle Cloud has been targeted by a threat actor, compromising 6 million records and ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Each Monday, the Tenable Exposure Management Academy provides the practical, real-world guidance you need to shift from vulnerability management to exposure management. In this blog, we share three ...

CyberArk Software (NASDAQ:CYBR – Get Free Report) had its price target reduced by equities research analysts at Truist ...

We’re excited to announce that Veriti has been recognized in Forrester’s The Unified Vulnerability Management Solutions Landscape, Q1 2025. We believe this recognition highlights our commitment to ...

The randomised trial saw more than half of patients dosed with Sunosi achieving clinical response to the therapy used to ...

Corebridge Financial Inc. lessened its stake in shares of CyberArk Software Ltd. (NASDAQ:CYBR – Free Report) by 3.1% during ...

Investing.com -- Alnylam Pharmaceuticals (NASDAQ: NASDAQ: ALNY) stock climbed 5% as trading resumed on Friday morning, following the company’s announcement that the FDA has approved AMVUTTRA for ...

The ASX health sector retreats again with Morgans analyst Scott Power noting various factors putting pressure on the sector ...